Your browser doesn't support javascript.
loading
Oral therapy for type 1 diabetes mellitus using a novel immunomodulator, FTY720 (fingolimod), in combination with sitagliptin, a dipeptidyl peptidase-4 inhibitor, examined in non-obese diabetic mice.
Tsuji, Takumi; Yoshida, Yuya; Fujita, Tetsuro; Kohno, Takeyuki.
Afiliação
  • Tsuji T; Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka.
  • Yoshida Y; Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka.
  • Fujita T; Research Institute for Production and Development, Kyoto, Japan.
  • Kohno T; Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka ; Research Institute for Production and Development, Kyoto, Japan.
J Diabetes Investig ; 3(5): 441-8, 2012 Oct 18.
Article em En | MEDLINE | ID: mdl-24843604
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Diabetes Investig Ano de publicação: 2012 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Diabetes Investig Ano de publicação: 2012 Tipo de documento: Article